Attention training for major depressive disorder
Part of Mental health clinical trials.
This trial tests a computer-based attention training that uses eye-tracking to help people with depression focus on positive information. It aims to reduce depressive symptoms by retraining attention patterns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a primary diagnosis of major depressive disorder (MDD).
- Your depression score on the MADRS scale must be 7 or higher.
- You need normal or corrected-to-normal vision (with glasses or contacts).
- You must not have a history of psychosis, bipolar disorder, or PTSD.
- You must not have high suicidal ideation or behavior.
- You must not have severe alcohol or cannabis use disorder, or any other substance use disorder (except nicotine).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a brain training technique called neurofeedback can help treat depression. By showing your brain activity in real time on a screen, you may learn to control the brain patterns linked to depression and feel better.
This trial uses a powerful MRI scanner to give you real-time feedback on brain activity linked to depression. You will learn to regulate that activity, which may reduce symptoms.
This trial tests a new kind of brain stimulation that uses special electrical currents to target areas linked to depression. It's for people who haven't gotten enough relief from standard antidepressants.
This trial tests if a non-invasive brain training technique called neurofeedback can help people with major depression improve how they manage emotions. You participate by doing computer tasks while your brain activity is measured and shown back to you, teaching you to regulate your emotions better.
This trial tests a new, non-invasive brain stimulation method (called kTMP) to see if it can improve anhedonia, which is the loss of interest or pleasure in things you used to enjoy. It is for people with depression who have significant anhedonia.
This study tests two methods of targeting repetitive transcranial magnetic stimulation (TMS) for depression: one using brain imaging to guide the treatment, and the other using a standard scalp measurement. The goal is to see if imaging-guided TMS works better for people with treatment-resistant depression.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.